echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Dig Dis Sci: Safety and efficacy analysis of sedation in patients with upper gastrointestinal bleeding undergoing emergency endoscopic treatment

    Dig Dis Sci: Safety and efficacy analysis of sedation in patients with upper gastrointestinal bleeding undergoing emergency endoscopic treatment

    • Last Update: 2022-11-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    Upper gastrointestinal bleeding (UGIB) is the most common gastrointestinal emergency, with a mortality rate of 5 to 10%.

    UGIB is broadly divided into variceal bleeding and non-variceal bleeding
    Ruptured esophageal varices can cause about 70% of cirrhosis UGIB
    In patients with non-varicose UGIB, the main cause is peptic gastroduodenal ulcer
    Helicobacter pylori (H.
    pylori) pylori) infection and the use of nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin, have been the leading cause of bleeding from peptic ulcer disease over the past few years, but with the widespread eradication of Helicobacter pylori, the epidemiology and pathophysiology of UGIB have changed
    Emergency endoscopic haemostasis is useful in all cases of UGIB, and guidelines recommend endoscopy within 24 hours
    Sedation adjuvant therapy in gastrointestinal endoscopy has become an important medical option
    in routine clinical care.
    When vital signs are stable, especially when the patient is agitated or anxious, sedation during emergency endoscopy is considered useful
    for safe and reliable emergency endoscopy.
    However, sedation may not be useful
    when the patient's general condition deteriorates or is hemodynamically unstable.
    The purpose of this retrospective study was to (1) compare clinical outcomes in patients treated with and without sedation during urgent endoscopy of UGIB, and (2) to determine the risk factors
    for death from UGIB in these patients.




    The researchers retrospectively collected 389 patients
    who underwent UGIB emergency endoscopy at the medical center from 2016 to 2021.
    Patients were divided into two groups: sedation and non-sedation during emergency endoscopy
    Clinical features, patient status on admission, and cause
    of UGIB were then assessed.
    Treatment outcomes and adverse events were assessed using propensity score matching (PSM), and risk factors
    for UGIB mortality were investigated using Cox multivariate analysis.

    The results of the study showed that the sedation group was significantly younger, had a higher proportion of men, and had a higher
    proportion of chronic liver disease.
    Blood pressure and hemoglobin levels were significantly elevated
    on admission in the sedation group.
    The main cause of bleeding is peptic ulcer, which is significantly higher
    in the non-sedative group.
    Propensity score matches created 133 matches
    The success rate of endoscopic hemostasis was similar between the two groups, but the operation time in the sedation group was significantly shorter than that in the non-sedation group (17.
    0 vs 20.
    2 min, P = 0.

    There was no significant difference
    between groups in adverse events.
    Cox multivariate analysis showed that red blood cell transfusion [hazard ratio (HR) 4.
    45, P < 0.
    02] and rebleeding (HR 3.
    30, P = 0.
    03) were associated
    with an increased risk of 30-day mortality due to UGIB.

    This study confirms that sedation reduces the duration
    of surgery during emergency endoscopy of UGIB.
    For safe endoscopic surgery, sedation during UGIB emergency endoscopy is acceptable


    Original source:

    Daisuke Yamaguchi.
    et al.
    Safety and Efficacy of Sedation During Emergency Endoscopy for Upper Gastrointestinal Bleeding: A Propensity Score Matching Analysis.
    Digestive Diseases and Sciences.

    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.